Inspire Medical Systems, Inc. INSP
897 filings, 5 in the last 30 days
SEC filing indexWhat the 8-Ks said
1 event in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Jan 12, 2026 CEO, CFO, COO or CAOCFO and CAO change “Buchholz’s decision to step down as Chief Financial Officer of the Company in August 2025, on January 9, 2026, the Board of Directors of the Company appointed Mr.” 8-K item 5.02 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 43 events
- Nov 2, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Nov 2, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Aug 24, 2026 Planned sale JOHN RONDONI (Officer) gave notice of a planned sale of 64 shares worth about $4KForm 144, approximate sale date Aug 24, 2026, under a 10b5-1 plan adopted May 22, 2026
- Aug 7, 2026 Planned sale JASON P KELLY (Officer) gave notice of a planned sale of 963 shares worth about $57KForm 144, approximate sale date Aug 7, 2026
- Aug 3, 2026 Planned sale John Rondoni (Chief Product and Innovation Officer) adopted a 10b5-1 trading planreported in the 10-Q, up to 73,067 shares, runs to Apr 10, 2027
- Aug 3, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Aug 3, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 24, 2026 8-K Director or officer change8-K item 5.02
- Jul 22, 2026 8-K Director or officer change8-K item 5.02
- Jun 26, 2026 8-K Regulation FD disclosure8-K item 7.01
- May 15, 2026 Planned sale JOHN RONDONI (Officer) gave notice of a planned sale of 2,641 shares worth about $114KForm 144, approximate sale date May 15, 2026
- May 14, 2026 Planned sale JOHN RONDONI (Officer) gave notice of a planned sale of 700 shares worth about $30KForm 144, approximate sale date May 14, 2026
- May 8, 2026 Planned sale SHAWN T MCCORMICK (Director) gave notice of a planned sale of 696 shares worth about $32KForm 144, approximate sale date May 8, 2026, under a 10b5-1 plan adopted Aug 29, 2025
- May 5, 2026 8-K Director or officer change, Bylaws or fiscal year changed, Shareholder vote results8-K items 5.02, 5.03, 5.07
- May 4, 2026 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- May 4, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Feb 13, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 11, 2026 8-K Quarterly results, Bylaws or fiscal year changed, Regulation FD disclosure8-K items 2.02, 5.03, 7.01
- Jan 12, 2026 Officer CFO and CAO changeBuchholz’s decision to step down as Chief Financial Officer of the Company in August 2025, on January 9, 2026, the Board of Directors of the Company appointed Mr.
- Jan 9, 2026 Planned sale JOHN RONDONI (Officer) gave notice of a planned sale of 109 shares worth about $10KForm 144, approximate sale date Jan 9, 2026, under a 10b5-1 plan adopted May 28, 2025
- Dec 2, 2025 Planned sale SHAWN T MCCORMICK (Director) gave notice of a planned sale of 1,200 shares worth about $152KForm 144, approximate sale date Dec 2, 2025, under a 10b5-1 plan adopted Aug 29, 2025
- Nov 28, 2025 Planned sale SHAWN T MCCORMICK (Director) gave notice of a planned sale of 2,000 shares worth about $255KForm 144, approximate sale date Nov 28, 2025, under a 10b5-1 plan adopted Aug 29, 2025
- Nov 17, 2025 8-K Other events8-K item 8.01
- Nov 3, 2025 Planned sale Shawn T McCormick (Director) adopted a 10b5-1 trading planreported in the 10-Q, up to 6,200 shares, runs to Aug 17, 2026
- Nov 3, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Nov 3, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Oct 10, 2025 8-K Regulation FD disclosure8-K item 7.01
- Aug 26, 2025 8-K Director or officer change, Regulation FD disclosure8-K items 5.02, 7.01
- Aug 11, 2025 8-K Other events8-K item 8.01
- Aug 4, 2025 Planned sale John Rondoni (Chief Product and Innovation Officer) ended a 10b5-1 trading planreported in the 10-Q, up to 21,832 shares, runs to May 30, 2025
- Aug 4, 2025 8-K Quarterly results, Director or officer change, Regulation FD disclosure8-K items 2.02, 5.02, 7.01
- Aug 4, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jun 13, 2025 8-K Regulation FD disclosure8-K item 7.01
- May 5, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- May 5, 2025 8-K Shareholder vote results8-K item 5.07
- May 5, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Feb 10, 2025 Planned sale Shawn T McCormick (Director) ended a 10b5-1 trading planreported in the 10-K, up to 8,600 shares
- Feb 10, 2025 Planned sale Randall Ban (EVP Patient Access and Therapy Development) adopted a 10b5-1 trading planreported in the 10-K, up to 25,000 shares
- Feb 10, 2025 Planned sale Richard J. Buchholz (Chief Financial Officer) adopted a 10b5-1 trading planreported in the 10-K, up to 15,000 shares
- Feb 10, 2025 Planned sale Bryan Phillips (General Counsel) adopted a 10b5-1 trading planreported in the 10-K, up to 6,152 shares
- Feb 10, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
- Feb 10, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Jan 13, 2025 8-K Quarterly results, Regulation FD disclosure8-K items 2.02, 7.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 12, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 9, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 2, 2026 | 10-Q | Quarterly report |
| Nov 2, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Oct 30, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Oct 16, 2026 | 4 | Insider trade |
| Oct 16, 2026 | 4 | Insider trade |
| Oct 16, 2026 | 4 | Insider trade |
| Oct 16, 2026 | 4 | Insider trade |
| Sep 2, 2026 | 4 | Insider trade |
| Aug 24, 2026 | 144 | Notice of planned insider sale |
| Aug 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 12, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Aug 11, 2026 | 4 | Insider trade |
| Aug 7, 2026 | 144 | Notice of planned insider sale |
| Aug 4, 2026 | 4 | Insider trade |
| Aug 3, 2026 | 10-Q | Quarterly report |
| Aug 3, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| Jul 31, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 28, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 27, 2026 | 4 | Insider trade |
| Jul 27, 2026 | 3 | New insider |
| Jul 24, 2026 | 8-K | Director or officer change |
| Jul 22, 2026 | 8-K | Director or officer change |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 17, 2026 | 4 | Insider trade |
| Jul 2, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Jun 26, 2026 | 8-K | Regulation FD disclosure |
| Jun 1, 2026 | SD | Conflict minerals report |
| May 27, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| May 19, 2026 | 4 | Insider trade |
| May 15, 2026 | 144 | Notice of planned insider sale |
| May 15, 2026 | 4 | Insider trade |
| May 15, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 14, 2026 | 144 | Notice of planned insider sale |
| May 14, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| May 11, 2026 | 4 | Insider trade |
| May 8, 2026 | 144 | Notice of planned insider sale |
| May 7, 2026 | S-8 | Shares registered for employee plans |
| May 5, 2026 | 8-K | Director or officer change, Bylaws or fiscal year changed, Shareholder vote results |
| May 4, 2026 | 10-Q | Quarterly report |
| May 4, 2026 | 8-K | Quarterly results, Regulation FD disclosure |
| May 4, 2026 | 4 | Insider trade |
| May 4, 2026 | 4 | Insider trade |
| May 4, 2026 | 4 | Insider trade |
| May 4, 2026 | 4 | Insider trade |
| May 4, 2026 | 4 | Insider trade |
| May 4, 2026 | 4 | Insider trade |
| May 4, 2026 | 4 | Insider trade |
| May 4, 2026 | 4 | Insider trade |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 16, 2026 | 4 | Insider trade |
| Apr 16, 2026 | 4 | Insider trade |
| Apr 16, 2026 | 4 | Insider trade |
| Apr 16, 2026 | 4 | Insider trade |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 20, 2026 | ARS | Annual report to shareholders |
| Mar 20, 2026 | DEFA14A | Extra proxy material |
| Mar 20, 2026 | DEF 14A | Proxy statement |
| Mar 9, 2026 | PRE 14A | |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 4 | Insider trade |
| Feb 24, 2026 | 3 | New insider |
| Feb 18, 2026 | 4 | Insider trade |
| Feb 18, 2026 | 4 | Insider trade |
| Feb 18, 2026 | 4 | Insider trade |
| Feb 18, 2026 | 4 | Insider trade |
| Feb 18, 2026 | 4 | Insider trade |
| Feb 18, 2026 | 4 | Insider trade |
| Feb 18, 2026 | 4 | Insider trade |
| Feb 17, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Feb 13, 2026 | 10-K | Annual report |
| Feb 11, 2026 | 8-K | Quarterly results, Bylaws or fiscal year changed, Regulation FD disclosure |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 4 | Insider trade |
| Feb 11, 2026 | 3 | New insider |
| Feb 10, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Jan 20, 2026 | 4 | Insider trade |
| Jan 20, 2026 | 4 | Insider trade |
| Jan 20, 2026 | 4 | Insider trade |
| Jan 20, 2026 | 4 | Insider trade |
| Jan 12, 2026 | 8-K | Quarterly results, Director or officer change, Regulation FD disclosure |
| Jan 12, 2026 | 4 | Insider trade |
| Jan 9, 2026 | 144 | Notice of planned insider sale |
| Dec 4, 2025 | 4 | Insider trade |
| Dec 2, 2025 | 144 | Notice of planned insider sale |
| Dec 1, 2025 | 4 | Insider trade |
| Nov 28, 2025 | 144 | Notice of planned insider sale |
| Nov 24, 2025 | 4 | Insider trade |
| Nov 17, 2025 | 8-K | Other events |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/INSP/export.csv") into a cell.